Subtherapeutic Ocular Penetration of Caspofungin and Associated Treatment Failure in Candida albicans Endophthalmitis
Authors:
Open Access
- 1 August 2005
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (3) , e27-e28
Abstract
Candida endophthalmitis represents the most serious ocular complication of candidemia. The pharmacokinetics and pharmacodynamics of fluconazole, amphKeywords
This publication has 14 references indexed in Scilit:
- Candida glabrata Endophthalmitis Treated Successfully with CaspofunginClinical Infectious Diseases, 2005
- Management of endogenous fungal endophthalmitis with voriconazole and caspofunginAmerican Journal of Ophthalmology, 2005
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- Determination of Vitreous, Aqueous, and Plasma Concentration of OrallyAdministered Voriconazole in HumansArchives of Ophthalmology (1950), 2004
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002
- ANALYSIS OF PREDISPOSING CLINICAL AND LABORATORY FINDINGS FOR THE DEVELOPMENT OF ENDOGENOUS FUNGAL ENDOPHTHALMITISRetina, 2001
- Candida endophthalmitis in non-neutropenic critically ill patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without NeutropeniaNew England Journal of Medicine, 1994
- Intraocular Candidiasis in Patients with CandidemiaOphthalmology, 1994
- Prospective Study of Candida Endophthalmitis in Hospitalized Patients With CandidemiaArchives of internal medicine (1960), 1989